Innocar 450 mg contains carboplatin, a platinum-based chemotherapy medicine that is widely used to treat various types of cancer. It is administered as an intravenous infusion under medical supervision, typically in hospital or clinical settings.

Carboplatin is known for its broad effectiveness and comparatively improved safety profile over its predecessor, cisplatin, especially in terms of kidney and nerve toxicity. Its main strength lies in treating solid tumors, and it is often used in combination with other anti-cancer drugs for maximum therapeutic effect.

Mechanism of Action

Carboplatin works by damaging the DNA inside cancer cells. Once it enters the bloodstream, the drug interacts with the DNA strands within the cell nucleus, forming bonds that prevent the DNA from replicating correctly.

This disruption stops cancer cells from dividing and triggers a process that leads to their death. Because cancer cells divide more rapidly than most normal cells, they are especially vulnerable to this kind of targeted damage.

Uses

Innocar 450 mg is indicated for the treatment of a variety of cancers, most commonly:

• Ovarian cancer, both initial and recurrent cases

• Lung cancer, particularly non-small cell lung cancer

• Head and neck cancers

• Breast cancer in selected settings

• Bladder and testicular cancer (in combination with other agents)

  Adverse Effects

  Carboplatin, like other chemotherapy agents, affects rapidly dividing cells — including healthy ones in the bone marrow, gastrointestinal tract, and hair follicles — leading to side effects. The severity and frequency of these effects can differ between individuals.

  Common Side Effects

  • Bone marrow suppression, leading to low white and red blood cell counts and platelets

  • Nausea and vomiting, usually controlled with supportive medications

  • Fatigue

  • Loss of appetite

  • Temporary hair thinning or loss